|
GB8808015D0
(en)
|
1988-04-06 |
1988-05-05 |
Ritter M A |
Chemical compounds
|
|
AU643427B2
(en)
|
1988-10-31 |
1993-11-18 |
Immunex Corporation |
Interleukin-4 receptors
|
|
AU665763B2
(en)
|
1991-05-03 |
1996-01-18 |
Seragen, Inc. |
Interleukin receptor targeted molecules for treatment of inflammatory arthritis
|
|
JP3315427B2
(ja)
|
1992-03-05 |
2002-08-19 |
大日本除蟲菊株式会社 |
皮膚炎治療剤
|
|
US5714146A
(en)
|
1992-08-26 |
1998-02-03 |
Board Of Regents Of The University Of Washington |
IL-4 bone therapy
|
|
EP0604693A1
(en)
|
1992-12-29 |
1994-07-06 |
Schering-Plough |
Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
|
|
ZA946875B
(en)
|
1993-09-07 |
1995-07-06 |
Smithkline Beecham Corp |
Recombinant il4 antibodies useful in treatment of il4 mediated disorders
|
|
DE69931377T2
(de)
|
1998-09-18 |
2007-05-10 |
Dynavax Technologies Corp., Berkeley |
Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren
|
|
US6927044B2
(en)
|
1998-09-25 |
2005-08-09 |
Regeneron Pharmaceuticals, Inc. |
IL-1 receptor based cytokine traps
|
|
CA2409267C
(en)
|
2000-05-26 |
2017-02-28 |
Immunex Corporation |
Interleukin-4 antagonists and compositions thereof
|
|
US7879328B2
(en)
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
|
JP4976636B2
(ja)
|
2000-07-26 |
2012-07-18 |
株式会社鳳凰堂 |
止痒性組成物及び創傷治癒促進組成物
|
|
CN1529618A
(zh)
|
2000-12-22 |
2004-09-15 |
�Ʒ� |
耐受性诱导
|
|
US20030103938A1
(en)
|
2001-05-09 |
2003-06-05 |
Alk-Abello A/S |
Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
|
|
BR0117009A
(pt)
|
2001-05-11 |
2004-04-20 |
Novartis Ag |
Composiçoes para utilização no tratamento de distúrbios associados a ige
|
|
CA2447795A1
(en)
|
2001-05-23 |
2002-11-28 |
Duotol Ab |
Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
|
|
WO2003048083A2
(en)
|
2001-11-30 |
2003-06-12 |
Biogen Idec Ma Inc. |
Antibodies against monocyte chemotactic proteins
|
|
MXPA04009418A
(es)
|
2002-03-29 |
2005-06-08 |
Schering Corp |
Anticuerpos monoclonales humanos par interleucina-5, y metodos y composiciones que comprenden los mismos.
|
|
MXPA05005528A
(es)
|
2002-11-26 |
2006-04-05 |
Alk Abello As |
Producto farmaceutico de alergeno.
|
|
ES2575547T3
(es)
|
2003-02-01 |
2016-06-29 |
Tanox, Inc. |
Anticuerpos anti-IgE de humano de alta afinidad
|
|
US7923209B2
(en)
|
2003-03-14 |
2011-04-12 |
Anergis, S.A. |
Allergen peptide fragments and use thereof
|
|
GB0407315D0
(en)
|
2003-07-15 |
2004-05-05 |
Cambridge Antibody Tech |
Human antibody molecules
|
|
EP1692184B1
(en)
|
2003-11-07 |
2012-03-07 |
Immunex Corporation |
Antibodies that bind interleukin-4 receptor
|
|
US7884054B2
(en)
|
2003-12-22 |
2011-02-08 |
Amgen Inc. |
Methods for identifying functional antibodies
|
|
AU2004308494B2
(en)
|
2003-12-23 |
2010-03-18 |
Genentech, Inc. |
Novel anti-IL 13 antibodies and uses thereof
|
|
EP1723173B1
(en)
|
2004-02-27 |
2008-05-14 |
Regeneron Pharmaceuticals, Inc. |
Il-4/il-13 specific polypeptides and therapeutic uses thereof
|
|
US7501121B2
(en)
|
2004-06-17 |
2009-03-10 |
Wyeth |
IL-13 binding agents
|
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
|
US20090098142A1
(en)
|
2004-06-09 |
2009-04-16 |
Kasaian Marion T |
Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
|
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
PE20060560A1
(es)
|
2004-08-03 |
2006-06-27 |
Novartis Ag |
Anticuerpos de interleucina-4 humana
|
|
JP5234445B2
(ja)
|
2004-10-05 |
2013-07-10 |
源一郎 杣 |
薬剤
|
|
WO2006083390A2
(en)
|
2004-12-07 |
2006-08-10 |
Children's Hospital Medical Center |
Eotaxin-3 in eosinophilic esophagitis
|
|
TWI306862B
(en)
|
2005-01-03 |
2009-03-01 |
Hoffmann La Roche |
Antibodies against il-13 receptor alpha 1 and uses thereof
|
|
CN102321174B
(zh)
|
2005-05-06 |
2013-10-16 |
津莫吉尼蒂克斯公司 |
Il-31单克隆抗体及使用方法
|
|
US20080044420A1
(en)
|
2005-05-11 |
2008-02-21 |
Heavner George A |
Anti-IL-13 antibodies, compositions, methods and uses
|
|
BRPI0617485B8
(pt)
|
2005-10-21 |
2021-05-25 |
Novartis Ag |
anticorpo anti-il-13 humano isolado, composição farmacêutica e uso do referido anticorpo
|
|
US8679545B2
(en)
|
2005-11-12 |
2014-03-25 |
The Regents Of The University Of California |
Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US8324192B2
(en)
|
2005-11-12 |
2012-12-04 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
EP2004691A1
(en)
|
2006-03-22 |
2008-12-24 |
Apogenix GmbH |
Antibody specific for human il-4 for the treament of cancer
|
|
RU2433138C2
(ru)
|
2006-06-02 |
2011-11-10 |
Ридженерон Фармасьютикалз, Инк. |
Антитела высокой аффинности к il-6-рецептору человека
|
|
JP4221018B2
(ja)
|
2006-08-31 |
2009-02-12 |
トヨタ自動車株式会社 |
頭部保護エアバッグ装置
|
|
ES2817756T3
(es)
|
2006-09-08 |
2021-04-08 |
Abbvie Bahamas Ltd |
Proteínas de unión a interleuquina-13
|
|
US7608693B2
(en)
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
|
KR101474227B1
(ko)
|
2006-10-02 |
2014-12-18 |
리제너론 파아마슈티컬스, 인크. |
사람 ｉｌ-4 수용체에 대한 고친화성 사람 항체
|
|
UA102994C2
(ru)
*
|
2007-03-22 |
2013-09-10 |
Дженентек, Инк. |
АНТИТЕЛО, КОТОРОЕ СПЕЦИФИЧНО СВЯЗЫВАЕТСЯ С IgE/M1' И ИНДУЦИРУЕТ АПОПТОЗ В ЭКСПРЕССИРУЮЩИХ IgE В-КЛЕТКАХ
|
|
EP2022507A1
(en)
|
2007-08-07 |
2009-02-11 |
Universität Hamburg |
Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy
|
|
EP2050764A1
(en)
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
|
WO2009061819A1
(en)
|
2007-11-05 |
2009-05-14 |
The Regents Of The University Of Colorado |
Minimally-invasive measurement of esophageal inflammation
|
|
JP5791898B2
(ja)
|
2007-11-30 |
2015-10-07 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
抗原結合性構築物
|
|
US8092804B2
(en)
|
2007-12-21 |
2012-01-10 |
Medimmune Limited |
Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
|
|
DE202008006598U1
(de)
|
2008-04-11 |
2008-10-02 |
Alk-Abelló A/S |
Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
|
|
US20090264392A1
(en)
|
2008-04-21 |
2009-10-22 |
Meritage Pharma, Inc. |
Treating eosinophilic esophagitis
|
|
AU2009322556A1
(en)
|
2008-12-01 |
2011-07-21 |
Children's Hospital Medical Center |
Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis
|
|
GB0904214D0
(en)
|
2009-03-11 |
2009-04-22 |
Ucb Pharma Sa |
Biological products
|
|
WO2010120511A2
(en)
|
2009-03-31 |
2010-10-21 |
Altair Therapeutics, Inc. |
Method of treating respiratory disorders
|
|
US8497528B2
(en)
|
2010-05-06 |
2013-07-30 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Method for fabricating a strained structure
|
|
CN107320722A
(zh)
|
2009-09-07 |
2017-11-07 |
Dbv技术公司 |
治疗嗜酸细胞性食管炎的方法
|
|
US8993347B2
(en)
|
2009-12-17 |
2015-03-31 |
Cornell University |
Methods for detecting antibodies in mucosal samples and device for sampling mucosal material
|
|
WO2011108008A2
(en)
|
2010-03-04 |
2011-09-09 |
Transgene Biotek Ltd. |
Antibody for targeted induction of apoptosis, cdc and adcc mediated killing of cancer cells, tbl-cln1
|
|
EP2585075B8
(en)
|
2010-06-24 |
2021-09-22 |
ViroPharma Biologics LLC |
Methods of treatment for esophageal inflammation
|
|
KR101867279B1
(ko)
|
2010-10-06 |
2018-06-15 |
리제너론 파아마슈티컬스, 인크. |
항―인터류킨―４ 수용체（ｉｌ－４ｒ） 항체를 함유하는 안정화된 제형
|
|
RU2013122123A
(ru)
|
2010-10-15 |
2014-11-20 |
Медиммьюн Лимитед |
Терапевтические средства для улучшения легочной функции
|
|
JP6013915B2
(ja)
*
|
2010-11-17 |
2016-10-25 |
中外製薬株式会社 |
血液凝固第ｖｉｉｉ因子の機能を代替する機能を有する多重特異性抗原結合分子
|
|
RU2453303C1
(ru)
|
2010-12-23 |
2012-06-20 |
Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") |
Фармацевтическая композиция для лечения атопического дерматита
|
|
EP2661631A4
(en)
|
2011-01-06 |
2014-05-21 |
Childrens Hosp Medical Center |
EXPRESSION PROFILES FOR OSSOPHAGEAL CYTOKINE IN EOSINOPHILIAN ESOPHAGITIS
|
|
US20130052190A1
(en)
|
2011-02-22 |
2013-02-28 |
Oxagen Limited |
CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions
|
|
US9928344B2
(en)
|
2011-06-21 |
2018-03-27 |
Children's Hospital Medical Center |
Diagnostic methods of eosinophilic esophagitis
|
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
EP2763683A1
(en)
|
2011-10-06 |
2014-08-13 |
N.V. Nutricia |
Treatment of eosinophilic esophagitis
|
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對ｂｃｍａ之e3以及ｃｄ３的結合分子
|
|
WO2013088109A1
(en)
|
2011-12-16 |
2013-06-20 |
Oxagen Limited |
Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
|
|
JP2015506950A
(ja)
|
2012-01-31 |
2015-03-05 |
ジェネンテック， インコーポレイテッド |
抗ｉｇ−ｅｍ１’抗体およびそれを用いる方法
|
|
WO2013155010A1
(en)
|
2012-04-09 |
2013-10-17 |
Children's Hospital Medical Center |
Non-invasive biomarkers for eosinophilic esophagitis
|
|
SG11201500889TA
(en)
|
2012-08-21 |
2015-03-30 |
Sanofi Sa |
Methods for treating or preventing asthma by administering an il-4r antagonist
|
|
BR112015005048A8
(pt)
|
2012-09-07 |
2018-01-30 |
Regeneron Pharma |
métodos para tratar dermatite atópica por administração de antagonista il-4r
|
|
US10132809B2
(en)
|
2012-10-10 |
2018-11-20 |
Rhote Island Hospital |
Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis
|
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Ｂｃｍａ抗原結合蛋白質
|
|
PL2953972T3
(pl)
|
2013-02-05 |
2021-03-08 |
Engmab Sàrl |
Metoda wyboru przeciwciał przeciwko bcma
|
|
AR095374A1
(es)
|
2013-03-15 |
2015-10-14 |
Amgen Res (Munich) Gmbh |
Moléculas de unión para bcma y cd3
|
|
AR095774A1
(es)
|
2013-04-05 |
2015-11-11 |
Genentech Inc |
Anticuerpos anti-il-4 y anticuerpos biespecíficos y sus usos
|
|
TWI755763B
(zh)
|
2013-06-04 |
2022-02-21 |
美商再生元醫藥公司 |
藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
|
|
MX368068B
(es)
|
2013-06-21 |
2019-09-18 |
Sanofi Biotechnology |
Antagonista de il-4r para usarse para tratar la poliposis nasal.
|
|
TWI634900B
(zh)
|
2013-07-11 |
2018-09-11 |
再生元醫藥公司 |
藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法
|
|
GB201317929D0
(en)
|
2013-10-10 |
2013-11-27 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
GB201317928D0
(en)
|
2013-10-10 |
2013-11-27 |
Ucl Business Plc |
Molecule
|
|
RU2552929C1
(ru)
|
2013-11-14 |
2015-06-10 |
Общество С Ограниченной Ответственностью "Фарминтерпрайсез" |
Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
|
|
IL315136A
(en)
|
2014-02-21 |
2024-10-01 |
Sanofi Biotechnology |
Methods for treating or preventing asthma by administering an il-4rantagonist
|
|
EP3110848B1
(en)
|
2014-02-28 |
2024-02-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating skin infection by administering an il-4r antagonist
|
|
EP2982692A1
(en)
|
2014-08-04 |
2016-02-10 |
EngMab AG |
Bispecific antibodies against CD3epsilon and BCMA
|
|
MX2017006286A
(es)
|
2014-11-14 |
2018-01-23 |
Sanofi Biotechnology |
Metodos para tratar sinusitis cronica con polipos nasales por administracion de un antagonista de il-4r.
|
|
EP3023437A1
(en)
|
2014-11-20 |
2016-05-25 |
EngMab AG |
Bispecific antibodies against CD3epsilon and BCMA
|
|
SMT201900596T1
(it)
|
2014-12-12 |
2019-11-13 |
Bluebird Bio Inc |
Recettori chimerici di antigene per bcma
|
|
WO2016130598A1
(en)
|
2015-02-09 |
2016-08-18 |
University Of Florida Research Foundation, Inc. |
Bi-specific chimeric antigen receptor and uses thereof
|
|
GB201504840D0
(en)
|
2015-03-23 |
2015-05-06 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
TWI787645B
(zh)
|
2015-04-13 |
2022-12-21 |
美商輝瑞股份有限公司 |
Ｃｄ３特異性抗體、治療性雙特異性抗體及其用途
|
|
RU2706582C2
(ru)
|
2015-04-13 |
2019-11-19 |
Пфайзер Инк. |
Химерные антигенные рецепторы, нацеленные на антиген созревания B-клеток
|
|
NL2014882B1
(en)
|
2015-05-29 |
2017-01-31 |
Citeq B V |
Allergy-specific immunotherapy compositions for use in the treatment of house-dust mite allergy.
|
|
CN105384825B
(zh)
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
一种基于单域抗体的双特异性嵌合抗原受体及其应用
|
|
PT3337824T
(pt)
|
2015-08-17 |
2020-09-10 |
Janssen Pharmaceutica Nv |
Anticorpos anti-bcma, moléculas de ligação a antigénio biespecíficas que ligam bcma e cd3, e suas utilizações
|
|
US20190256608A1
(en)
|
2015-12-01 |
2019-08-22 |
Glaxosmithkline Intellectual Property Development Limited |
Combination treatments and uses and methods thereof
|
|
WO2017130223A2
(en)
|
2016-01-29 |
2017-08-03 |
Virocan Therapeutics Pvt. Ltd. |
A chimeric antigen receptor specific to b-cell maturation antigen, a recombinant expression vector and a method thereof
|
|
MY190421A
(en)
|
2016-02-03 |
2022-04-21 |
Amgen Res Munich Gmbh |
Bcma and cd3 bispecific t cell engaging antibody constructs
|
|
IL260732B2
(en)
|
2016-02-17 |
2024-08-01 |
Seagen Inc |
BCMA antibodies and their use for the treatment of cancer and immune disorders
|
|
CA3014202A1
(en)
|
2016-02-19 |
2017-08-24 |
Regeneron Pharmaceuticals, Inc. |
Methods for enhancing efficacy of a vaccine by administering an il-4r antagonist
|
|
KR102584280B1
(ko)
|
2016-04-01 |
2023-10-04 |
카이트 파마 인코포레이티드 |
키메라 항원 및 t 세포 수용체 및 사용 방법
|
|
JP6202480B1
(ja)
|
2016-04-22 |
2017-09-27 |
マツダ株式会社 |
車両用挙動制御装置
|
|
AU2017276706B2
(en)
|
2016-06-07 |
2024-08-15 |
Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft |
Chimeric antigen receptor and CAR-T cells that bind BCMA
|
|
IL299221A
(en)
|
2016-06-21 |
2023-02-01 |
Teneobio Inc |
CD3 binding antibodies
|
|
TWI728172B
(zh)
|
2016-08-18 |
2021-05-21 |
美商愛戴爾製藥股份有限公司 |
治療嗜伊紅性食道炎之方法
|
|
EP3506931B1
(en)
|
2016-09-01 |
2024-07-31 |
Regeneron Pharmaceuticals, Inc. |
Methods for preventing or treating allergy by administering an il-4r antagonist
|
|
CN109963577B
(zh)
|
2016-09-22 |
2024-03-12 |
瑞泽恩制药公司 |
用于通过施用il-4r抑制剂治疗严重特应性皮炎的方法
|
|
SG11201903359RA
(en)
|
2016-11-02 |
2019-05-30 |
Engmab Sarl |
Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma
|
|
KR20190082241A
(ko)
|
2016-11-04 |
2019-07-09 |
블루버드 바이오, 인코포레이티드. |
항-bcma car t 세포 조성물
|
|
CA3052779A1
(en)
|
2017-02-17 |
2018-08-23 |
Fred Hutchinson Cancer Research Center |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
|
EP3615068A1
(en)
|
2017-04-28 |
2020-03-04 |
Novartis AG |
Bcma-targeting agent, and combination therapy with a gamma secretase inhibitor
|
|
GB201709508D0
(en)
|
2017-06-15 |
2017-08-02 |
Autolus Ltd |
Chimeric antigen receptor
|
|
US20200138865A1
(en)
|
2017-06-30 |
2020-05-07 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Anti-b-cell maturation antigen chimeric antigen receptors with human domains
|
|
AU2018311503C1
(en)
|
2017-08-01 |
2023-11-30 |
Medimmune, Llc |
BCMA monoclonal antibody-drug conjugate
|
|
WO2019028367A1
(en)
|
2017-08-04 |
2019-02-07 |
Regeneron Pharmaceuticals, Inc. |
METHODS OF TREATING ESOPHAGITIS WITH ACTIVE EOSINOPHILES
|
|
PT3515465T
(pt)
|
2017-08-18 |
2024-03-04 |
Regeneron Pharma |
Métodos para o tratamento de uma dermatite atópica grave mediante a administração de um inibidor de il-4r
|
|
PL3703818T3
(pl)
|
2017-10-30 |
2024-03-25 |
Sanofi Biotechnology |
Antagonista IL-4R do zastosowania w sposobie leczenia lub zapobiegania astmie
|
|
BR112020020387A2
(pt)
|
2018-05-13 |
2021-01-19 |
Regeneron Pharmaceuticals, Inc. |
Métodos para o tratamento de dermatite atópica por administração de um inibidor de il-4r
|
|
KR20210020015A
(ko)
|
2018-06-14 |
2021-02-23 |
아지노모토 가부시키가이샤 |
항체에 대한 친화성 물질 및 생체 직교성 관능기를 갖는 화합물 또는 이의 염
|
|
BR112021021195A2
(pt)
|
2019-05-01 |
2022-03-03 |
Regeneron Pharma |
Métodos para tratamento ou prevenção da asma pela administração de um antagonista de il-33
|
|
AU2020325021B2
(en)
|
2019-08-05 |
2024-05-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
|
|
MX2022001247A
(es)
|
2019-08-05 |
2022-04-25 |
Regeneron Pharma |
Metodos para tratar dermatitis atopica mediante la administracion de un antagonista il-4r.
|
|
JP2023504204A
(ja)
|
2019-12-09 |
2023-02-01 |
サノフィ・バイオテクノロジー |
デジタル的に識別されたｉｌ－４／ｉｌ－１３関連障害を治療する方法
|
|
US20230102151A1
(en)
|
2020-03-27 |
2023-03-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating atopic dermatitis by administering an il-4r antagonist
|
|
CN115768516A
(zh)
|
2020-05-22 |
2023-03-07 |
瑞泽恩制药公司 |
通过施用il-4r抑制剂治疗嗜酸细胞性食管炎的方法
|
|
WO2022150605A1
(en)
|
2021-01-08 |
2022-07-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
|